Invesco
ORGO icon

Invesco’s Organogenesis Holdings ORGO Stock Holding History

Invesco’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$410K Buy
168,904
+6,167
+4% +$15.1K ﹤0.01% 3320
2026
Q1 		$386K Sell
162,737
-12,482
-7% -$43.2K ﹤0.01% 3255
2025
Q4 		$908K Buy
175,219
+15,790
+10% +$76.5K ﹤0.01% 2950
2025
Q3 		$673K Buy
159,429
+10,732
+7% +$49.9K ﹤0.01% 3110
2025
Q2 		$544K Sell
148,697
-920,555
-86% -$3.43M ﹤0.01% 3122
2025
Q1 		$4.62M Buy
1,069,252
+947,705
+780% +$3.83M ﹤0.01% 2200
2024
Q4 		$389K Buy
121,547
+1,849
+2% +$6.2K ﹤0.01% 3329
2024
Q3 		$342K Sell
119,698
-147,449
-55% -$414K ﹤0.01% 3376
2024
Q2 		$748K Buy
267,147
+43,800
+20% +$118K ﹤0.01% 3090
2024
Q1 		$634K Buy
223,347
+198,484
+798% +$675K ﹤0.01% 3213
2023
Q4 		$102K Buy
24,863
+2,791
+13% +$7.82K ﹤0.01% 3681
2023
Q3 		$70.2K Buy
22,072
+2,286
+12% +$7.26K ﹤0.01% 3769
2023
Q2 		$65.7K Sell
19,786
-8,513
-30% -$25.2K ﹤0.01% 3791
2023
Q1 		$60.3K Sell
28,299
-861,453
-97% -$2.13M ﹤0.01% 3748
2022
Q4 		$2.39M Buy
889,752
+295,080
+50% +$861K ﹤0.01% 2575
2022
Q3 		$1.93M Buy
594,672
+67,819
+13% +$306K ﹤0.01% 2659
2022
Q2 		$2.57M Buy
526,853
+15,083
+3% +$92.8K ﹤0.01% 2594
2022
Q1 		$3.9M Sell
511,770
-55,264
-10% -$428K ﹤0.01% 2496
2021
Q4 		$5.24M Buy
567,034
+200,293
+55% +$2.13M ﹤0.01% 2380
2021
Q3 		$5.22M Buy
366,741
+91,711
+33% +$1.42M ﹤0.01% 2361
2021
Q2 		$4.57M Sell
275,030
-163,382
-37% -$3.05M ﹤0.01% 2464
2021
Q1 		$7.99M Buy
438,412
+427,096
+3,774% +$5.79M ﹤0.01% 2094
2020
Q4 		$85K Buy
+11,316
New +$53.7K ﹤0.01% 3660

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Invesco's ORGO Position: Q2 2026 in Review

Invesco increased its Organogenesis Holdings (ORGO) stake by 3.8% in Q2 2026, buying an estimated $15.1K and bringing the position to 168,904 shares worth $410K. The position accounts for ﹤0.01% of the portfolio, ranked #3320.

Invesco first reported a position in ORGO in Q4 2020 and has held it in 23 quarters since. The position peaked at $7.99M in Q1 2021. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Invesco held 168,904 shares of Organogenesis Holdings worth $410K as of Q2 2026.
  • Invesco bought 6,167 Organogenesis Holdings shares in Q2 2026, an estimated $15.1K.
  • Organogenesis Holdings made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3320 holding.
  • Invesco first reported a position in Organogenesis Holdings in Q4 2020 and has held it in 23 quarters since.
  • Invesco's Organogenesis Holdings position peaked at $7.99M in Q1 2021.
  • 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.